Characteristics | Details |
---|---|
Active Ingredients | Avanafil 200 mg, Dapoxetine 60 mg |
Classification | Phosphodiesterase Inhibitor, SSRI |
Dosage Forms | Tablets |
Storage Conditions | Room Temperature, Away from Moisture |
Learn More About Extra Super Avana |
Generic Names and Composition
The pharmaceutical world introduces Extra Super Avana, combining Avanafil 200 mg and Dapoxetine 60 mg. This dual-action medication brings together the potency of a phosphodiesterase inhibitor with a selective serotonin reuptake inhibitor. Avanafil enhances blood flow, targeting erectile dysfunction. Dapoxetine addresses premature ejaculation by altering serotonin levels.
Marketed under several generic names, this formula allows various manufacturers to create equivalents. The robust combination targets male sexual health, delivering comprehensive solutions. Patients find accessibility improved through different nomenclatures.
Despite different branding, the integrity of the compound remains intact. The effectiveness hinges on its unique synergy. The inclusion of both substances augments the therapeutic impact.
Off-Label Uses and Potential
Although designed for sexual dysfunction, Extra Super Avana sees occasional off-label uses. Clinicians sometimes explore its impact on conditions requiring serotonin modulation. Such uses remain rare and typically under careful supervision.
Physicians contemplate the drug’s implications for psychological conditions. By modulating serotonin, it could theoretically affect mood disorders. This aspect remains largely uncharted, yet intriguing.
Off-label application demands rigorous assessment. The absence of substantial research limits its widespread adoption. However, its potential remains a topic of interest within clinical circles.
FDA-Approved Indications and Efficacy
The FDA approves Extra Super Avana primarily for male erectile dysfunction and premature ejaculation. The dual-action nature provides a broader scope of action than single-agent treatments. This approval underscores its effectiveness.
Clinical trials underscore the compound’s reliability. Users report marked improvements in sexual performance. These outcomes affirm the medication’s place in therapeutic regimens.
Both components work in harmony, addressing two pivotal concerns simultaneously. The synergistic effect enhances the patient’s experience. FDA approval reinforces its therapeutic legitimacy.
Considerations in Pregnancy and Breastfeeding
Extra Super Avana is contraindicated during pregnancy. Its effects on fetal development remain unknown. It also extends to breastfeeding, where potential risks to infants are unstudied.
Women of childbearing age should employ effective contraceptive measures. The medication’s benefits do not outweigh potential reproductive risks.
Healthcare providers emphasize caution. Until further data emerges, the drug remains unsuitable for pregnant or breastfeeding women.
Toxicity and Safety Profile
While generally safe, Extra Super Avana may induce side effects. Common issues include headache, flushing, and dizziness. These symptoms usually resolve without intervention.
Serious adverse reactions, though rare, require immediate attention. They include severe hypotension and prolonged erections. Patients should discontinue use and seek medical advice if such symptoms occur.
Monitoring is advisable for those with cardiovascular conditions. Drug interactions might compound side effects, demanding a cautious approach.
Acquiring Extra Super Avana Online
The digital marketplace offers Extra Super Avana for purchase. Online platforms provide convenience and often competitive pricing. Potential buyers should verify the legitimacy of sellers.
Reputable pharmacies ensure product authenticity. Patients should seek consultation before ordering. A prescription remains necessary to obtain the drug responsibly.
Online acquisition enhances accessibility. However, safeguarding health through cautious purchasing practices is vital.